Evaluating of colchicine use patterns and attack frequency of familial Mediterranean fever patients in the COVID-19 pandemic

Basit Öğe Kaydı
dc.authorid0000-0003-0160-0377en_US
dc.authorid0000-0001-7191-2240en_US
dc.authorscopusid58017818000en_US
dc.authorscopusid56031176400en_US
dc.authorwosidABE-4593-2022en_US
dc.authorwosid-en_US
dc.contributor.authorAkcan, Mehmet Berkay
dc.contributor.authorAlbuz, Burcu
dc.contributor.authorÖzdemir, Özturk
dc.contributor.authorSılan, Fatma
dc.date.accessioned2024-01-24T06:29:38Z
dc.date.available2024-01-24T06:29:38Z
dc.date.issued2023en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractFamilial Mediterranean Fever (FMF) is an autosomal recessive and dominant inherited disease and is the most common autoinflamma-tory disease characterized by recurrent episodes of fever, arthritis, and polyserositis.1Colchicine is the main therapeutic agent used in FMF patients.2,3It reduces attacks, improves quality of life, and most importantly, prevents amyloidosis.3 The lifetime use of colchicine is recom-mended in individuals with M694V homozygous variant or com-pound heterozygous with other pathogenic variants.en_US
dc.identifier.citationAkcan, M. B., Albuz, B., Özdemir, O., & Sılan, F. (2023). Evaluating of colchicine use patterns and attack frequency of familial Mediterranean fever patients in the COVID‐19 pandemic. International Journal of Rheumatic Diseases, 26(5), 988–991. https://doi.org/10.1111/1756-185X.14517en_US
dc.identifier.doi10.1111/1756-185X.14517
dc.identifier.endpage991en_US
dc.identifier.issn1756-1841
dc.identifier.issn1756-185X
dc.identifier.issue5en_US
dc.identifier.pmid36480443
dc.identifier.scopus2-s2.0-85144061111
dc.identifier.startpage988en_US
dc.identifier.urihttps://doi.org/10.1111/1756-185X.14517
dc.identifier.urihttps://hdl.handle.net/20.500.12428/5359
dc.identifier.volume26en_US
dc.identifier.wosWOS:000895343700001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorAkcan, Mehmet Berkay
dc.institutionauthorSılan, Fatma
dc.language.isoen
dc.publisherJohn Wiley and Sons Incen_US
dc.relation.ispartofInternational Journal of Rheumatic Diseasesen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectCase-Control Studiesen_US
dc.subjectColchicine Familial Mediterranean Feveren_US
dc.subjectHumans Pandemicsen_US
dc.titleEvaluating of colchicine use patterns and attack frequency of familial Mediterranean fever patients in the COVID-19 pandemic
dc.typeLetter

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Fatma_Silan_Letter.pdf
Boyut:
351.24 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Letter
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu